Navigation Links
TGen/VARI president Dr. Jeffrey Trent appointed Foreign Trade Counselor by Luxembourg
Date:5/20/2011

San Francisco and Luxembourg City, May 20, 2011 Dr. Jeffrey M. Trent, F.A.C.M.G., a nationally recognized leader in the science of genetics related to cancer, has been appointed Foreign Trade Counselor of Luxembourg in the United States.

Dr. Trent is President and Research Director of the Translational Genomics Research Institute (TGen), Phoenix, Arizona, and Van Andel Research Institute (VARI), Grand Rapids, Michigan. Both non-profit biomedical research institutes study the genetic origins of human disease and how to quickly bring new treatments to patients.

He has been a leader in promoting cooperation in science, technology, and economic development between Luxembourg and the United States. He has played a pivotal role in building the Luxembourg personalized medicine infrastructure (see www.tgen.org/news/index.cfm?newsid=1167 and www.biomedicine.lu), including the Integrated Biobank of Luxembourg and the lung cancer research and development projects with the Luxembourg National Health Research Center (CRP-Sante).

Dr. Trent holds a Ph.D. in Genetics from the University of Arizona, Tucson. Before TGen and VARI, Dr. Trent served as the founding Scientific Director of the U.S. National Institutes of Health's National Human Genome Research Institute. He has held faculty positions at the University of Arizona, Arizona State University, the University of Michigan and Johns Hopkins University. He has authored or co-authored more than 300 scientific publications, and delivered hundreds of invited lectures.

He has received numerous honors and awards, and has sat on the editorial boards of a dozen scientific publications. He specializes in developing and integrating novel tools based on the Human Genome Project, that help provide information related to the diagnosis and treatment of human cancers and other complex diseases.

"I'm honored by this appointment and look forward to continuing to support the efforts to develop the biomedical knowledge-based workforce in Luxembourg," said Dr. Trent. "All of us recognize that technology fuels the global environment and clearly is shaping business and competition in new ways. The work coming out of the Human Genome project is a picture of what lies ahead, and Luxembourg seems poised to help build economic value around their growing personalized medicine programs. I look forward to trying to help be part of their success."

Dr. Trent will work with the Luxembourg Trade and Investment Offices located in San Francisco and New York.

"Luxembourg welcomes Dr. Trent to our outstanding team of Foreign Trade Counselors," said Jeannot Kreck, Luxembourg Minister of the Economy and Foreign Trade. "He has significantly assisted our Government in building relationships with the science and business communities throughout the United States, and we are very excited to welcome Dr. Trent in this new role."


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related medicine news :

1. Senator Janis Lee Sponsors Senate Resolution Supporting Kevin Saunders for Chairman of the President's Council on Physical Fitness & Sports
2. Quantum Health Appoints Stark as Executive Vice President of Sales
3. Medical Malpractice Survivors Urge President Obama to Keep Tort Reform out of Health Insurance Bill
4. Ex-President Clinton Undergoes Heart Procedure
5. March of Dimes National Ambassador Families and Senior Leadership Meet with President Obama
6. American Heart Association Comment on Hospitalization of President Bill Clinton
7. Ex-President Clinton Said To Be Fine After Heart Procedure
8. Majority of Americans Approve of President Obamas Handling of Afghanistan and National Security But Disapprove of Handling of Economic Issues, Per Franklin & Marshall College Poll With Hearst Television
9. Private Sector, President's Malaria Initiative Join Forces to Strengthen Angolas Capacity to Control Mosquitoes
10. Longtime Quality Assurance Executive Randy Johnson Joins White Pine Systems as Vice President of Product Services
11. Peter Harker Joins Prometheus Research as Vice President of Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... selected to renovate and improve the Ramsey County Medical Examiners Facility located in ... Hospital, the $2.5 million project is scheduled to start in late 2017/early 2018. ...
(Date:7/21/2017)... ... 21, 2017 , ... Bernard R. Bach, Jr., MD, orthopaedic surgeon at Rush ... Society of Sports Medicine (AOSSM) , received the 2017 Robert E. Leach Sports Medicine ... Canada. This prestigious award is given annually to honor those who have made a ...
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... ... 4th-year medical students improve their chances of acceptance to a residency in a ... who have earned degrees outside the U.S. , According to data released by ...
(Date:7/21/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 21, ... ... with over 80% follow-up at 10 years, researchers from the Multicenter Orthopaedics Outcome ... knee-related quality of life a decade after surgery, though activity levels decline over ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ChenMed ... MD, has joined JenCare Senior Medical Center as Richmond Chief Medical Officer. ... School of Medicine, and Associate Chief Medical Officer of Ambulatory Services for the UVA ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... 2017  New York City-based market research firm Kalorama Information ... aware of.  From new products to new costs, to the ... recently completed study, Potential Pipeline Disruptors . ... 1.  Age-Driven Growth - True Impact Moment Arriving ... the impact the growing population and, to a more extreme ...
(Date:7/11/2017)... , July 11, 2017  The global market ... revenues of approximately $394.1 million in 2016.  Although in ... of solid growth, in particular as a result of ... practice, and the recent introduction of a significant number ... for less-invasive testing of tumor biomarkers to guide treatment ...
(Date:7/10/2017)... Md. , July 10, 2017 The ... non-animal test methods, is the recipient of a VITROCELL® ... the PETA International Science Consortium. The device, which is ... used to expose human lung cells to airborne test ... IIVS will use the VITROCELL® system for testing combustible ...
Breaking Medicine Technology: